<code id='329E258014'></code><style id='329E258014'></style>
    • <acronym id='329E258014'></acronym>
      <center id='329E258014'><center id='329E258014'><tfoot id='329E258014'></tfoot></center><abbr id='329E258014'><dir id='329E258014'><tfoot id='329E258014'></tfoot><noframes id='329E258014'>

    • <optgroup id='329E258014'><strike id='329E258014'><sup id='329E258014'></sup></strike><code id='329E258014'></code></optgroup>
        1. <b id='329E258014'><label id='329E258014'><select id='329E258014'><dt id='329E258014'><span id='329E258014'></span></dt></select></label></b><u id='329E258014'></u>
          <i id='329E258014'><strike id='329E258014'><tt id='329E258014'><pre id='329E258014'></pre></tt></strike></i>

          Wikipedia

          knowledge

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Eli Lilly buys Point Biopharma in radiopharmaceuticals play
          Eli Lilly buys Point Biopharma in radiopharmaceuticals play

          DarronCummings/APAcouplebillionhere,acouplebillionthere,andprettysoonEliLillyhopesitwillbetalkingabo

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          A Q&A with the global head of Boehringer Ingelheim's innovation unit

          MichelPairetCourtesyBoehringerIngelheimLONDON—Ataneventherelastweek,theGermanpharmaceuticalfirmBoehr